Find Funding Opportunities

Reissue of RFA-NS-18-032. The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors (PDs) /Principal Investigators (PIs) whose records of research achievement demonstrate their ability to make major contributions to neuroscience. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PI's recent NINDS support (Part 2, Section II) This greater funding stability will provide eligible investigators at nearly all career stages increased freedom and flexibility, allowing them to be more adventurous in their research, take greater risks, embark upon research that breaks new ground, undertake research projects that require a longer timeframe, and/or extend previous discoveries in new directions. Research supported through the RPA must be within the scope of the NINDS mission (http://www.ninds.nih.gov/about_ninds/mission.htm). Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center will not be considered through this program. Other anticipated benefits of the RPA include: A more stable funding environment, facilitating the pursuit of longer-term research goals; Flexible funding, enabling investigators to pursue research opportunities as they arise, not tied to specific aims; Reduced time spent writing grant applications and managing multiple grant awards, thereby allowing investigators to spend more time conducting and overseeing research; and More time for PDs/PIsto mentor junior scientists. Eligibility to apply through this FOA is limited to investigators who currently have at least one active NINDS R01 or R01 equivalent grant (defined here as R00, R01, R37, R56, DP1 or DP2 awards), and who have had an active R01 equivalent grant from NINDS in each of the past 5 years, with no more than one of those years in a no cost extension.

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Notice Special Interest: Administrative Supplements the U.S.-Japan Brain Research Cooperative Program BRCP) - U.S. Entity Admin Supp) Notice Number: NOT-NS-20-024 Key Dates Release Date: 05, 2020 First Available Due Date: September 07, 2020 Expiration Date:September 08, 2022 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) National Institute Aging NIA) National Institute Biomedical Imaging Bioengineering NIBIB) National Institute Dental Craniofacial Research NIDCR) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Center Complementary Integrative Health NCCIH) Purpose National Institutes Health NIH) announces continuation the U.S. entity the U.S.-Japan Brain Research Cooperative Program BRCP). administrative supplement program provide funds currently active research grants are currently supported one the participating NIH Institutes Centers. Notice soliciting administrative supplements the following mechanisms ONLY:DP1,DP2,DP5,R01,R03,R21,R33,R34,R37,R61,U01,UH2, andUH3. purpose the BRCP to promote scientist exchange, training, collaborations basic, translational clinical research between neuroscientists the U.S. Japan. U.S. entity the BRCP supports following activities: 1) Visit U.S. scientists conduct collaborative research and/or acquire advanced research skills Japanese institutions, 2) Joint workshops exchange scientific information to foster collaborations. Background agreement ldquo;Cooperation Research Development Science Technology signed the President the United States the Prime Minister Japan May 1, 1980, has subsequently renewed extended. Under umbrella this Agreement, National Institute Neurological Disorders Stroke NINDS) the National Institute Physiological Sciences NIPS), Okazaki National Research Institutes, Japan, signed Memorandum Understanding a Brain Research Cooperative Program BRCP) November 29, 2000. Since inception the U.S. BRCP 2002, NIH successfully supported U.S. neuroscientists collaborative activities Japanese institutions, joint workshops the neurosciences. Japanese entity the BRCP been active since 2001. Details the program available http://www.nips.ac.jp/jusnou/english/. Within funding guidelines the BRCP program, country supports own scientists participate the aforementioned activities. BRCP Activities Supported the NIH A. Collaborative Research Fund Collaborative Research Fund provides support the travel lodging expenses the U.S. scientists visit Japan. visit the institution Japan be performed the PD/PI, collaborators, postdoctoral fellows students work the collaborative project. Support the Collaborative Research Fund be used one multiple trips. duration the supplement one year. supplement be carried over the next fiscal year, prior approval NIH Program staff. B. Workshop Fund U.S. Workshop Fund provides partial support joint workshops. U.S. Japan funding agencies the BRCP provide parallel support joint-workshops. entity support travel lodging expenses the joint-workshop participants their own country. the joint workshop be held the U.S., U.S. entity the BRCP support logistical meeting expenses. the joint workshop be held Japan, Japan entity support logistical meeting expenses. proposed workshop should at least co-organizer the U.S. one Japan. Co-organizers encouraged work together develop workshop applications. U.S. co-organizer must an active grant a participating NIH Institute Center. Workshop applications U.S. co-organizers should submitted response this FOA. Similarly, co-organizers Japan should submit application the NIPS. See:http://www.nips.ac.jp/jusnou/eng/ Applicants encouraged use Workshop Fund compensate travel lodging individuals groups are underrepresented the biomedical, clinical, behavioral social sciences encourage participation, the planning implementation of, well participation in, proposed workshop. NOT-OD--20-031. support junior investigators, postdoctoral fellows, graduate students also encouraged. Areas research interests the participating NIH Institutes Centers NINDS supports basic, translational clinical research understand structure function the nervous system mechanisms underlying neurological disorders stroke. Awardees projects funded the NIH BRAIN Initiative braininitiative.nih.gov/) encouraged submit supplement requests collaborative efforts are within scope this FOA NIHs goals the BRAIN Initiative, defined the strategic planning report, BRAIN 2025: Scientific Vision. Investigators encouraged contact potential collaborators participating related efforts led Japan such the Brain/MINDS project http://brainminds.jp/en/). Collaborations promote interdisciplinary approaches research questions within NINDS mission also strongly encouraged. NIA supports broad spectrum research training aimed a better understanding age-related normal pathological changes the structure function the nervous system how such changes affect behavior. addition, NIA encourages cross-country collaborations research related the etiology, diagnosis, progression, treatment Alzheimers Disease AD). mission includes basic clinical studies the nervous system, clinical trials interventions therapeutic modalities, epidemiological research identify risk factors to establish prevalence incidence estimates pathologic conditions aging AD. mission NIBIB to improve human health leading development accelerating application biomedical technologies. NIBIB encourages submission applications support development bioengineering biomedical imaging technologies. NIDA supports basic, clinical, applied research the causes, consequences, prevention treatment drug abuse addiction. NIDCD encourages collaborative basic clinical biomedical bio-behavioral research the communication sciences hearing, balance, smell, taste, voice, speech language. NIDCR supports wide range basic, clinical translational research painful disorders the orofacial region including temporomandibular joint disorders, trigeminal neuropathies, burning mouth syndrome, oral cancer pain, dental pain, other conditions; well chronic pain conditions co-morbid orofacial pain. NIEHS supports basic mechanistic human based studies the interplay environmental neurotoxicant exposure neuronal dysfunction across life span. includes influence prenatal exposure both childhood adult dysfunction/disease well adult exposures the aging brain. NIMH supports research transform understanding treatment mental illnesses through basic, translational, clinical, services research, paving way prevention, recovery, cure. NIMH encourages innovative thinking ensure a full array novel scientific perspectives used further discovery the evolving science brain, behavior, experience. NIMH now focusing an experimental medicine approach evaluating novel interventions mental illnesses. strategy designed increase value the public investment early clinical trials ensuring informed, data-driven decisions an early stage behavioral, device, pharmacologic studies. NCCIH supports rigorous scientific investigation, usefulness safety complementary integrative health approaches, their roles improving health health care. includes collaborations involving studying neurobiological mechanisms natural products such herbs, prebiotics, probiotics, dietary supplements) mind body interventions such acupuncture, meditation, manual therapy, yoga, Tai Chi, hypnosis, music art therapy, etc) their effects pain, sleep, stress, anxiety, emotional well-being, and/or behavioral changes. NCATS supports development disruptive innovative methods technologies will enhance development, testing implementation diagnostics therapeutics across wide range human diseases conditions. includes translational early stage clinical research rare neurologic brain conditions. Award Project Period be eligible, parent award must active the current fiscal year i.e., parent award received funds the current fiscal year is in extension period), the research proposed the supplement should requested one year should accomplished within currently approved project period the existing parent award. awarding institute consider no-cost extension up an additional year the conclusion the first year. Award Budget Application budgets Collaborative Research Funds limited 25,000 direct cost. to 2,500 be used research supplies. Funds the BRCP not used salary support the PD/PI, collaborators, postdoctoral fellows, students collaborators. Travel costs associated Collaborative Research Fund requests should exceed U.S. Government Foreign Per Diem Rates Japan. See:http://aoprals.state.gov/content.asp?content_id=184&menu_id=81/ Application budgets Workshop Funds limited 35,000 direct cost. support travel lodging expenses should exceed U.S. Government Per Diem Rates http://www.gsa.gov/portal/content/101518; orhttp://aoprals.state.gov/content.asp?content_id=184&menu_id=81/). honorarium allowed. is recommended investigators secure additional funding support other sources, needed. announcement for supplements existing projects. research proposed the NIH grantee the supplement application must within original scope the NIH-supported grant award. Similarly, scope the proposed collaborative research activities workshops should well aligned the aims the parent award. Eligible Individuals Program Director/Principal Investigator) Individual(s) must hold active grant award one the participating NIH Institutes Centers. supplements parent awards include multiple PDs/PIs, supplement be requested any all the PDs/PIs accordance the existing leadership plan) must submitted the awardee institution the parent award. New early stage investigators encouraged apply, well established neuroscientists. Individuals diverse backgrounds, including underrepresented racial ethnic groups, individuals disabilities, women always encouraged apply NIH support. Application Submission Information Applications this initiative must submitted using following opportunity its subsequent reissued equivalent. PA-18-591- Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) instructions theSF424 R&R) Application GuideandPA-18-591must followed, the following additions: Application Due Date(s) September 7, 2020, September 7, 2021, September 7, 2022, 5:00 PM local time applicant organization. funding consideration, applicants must include ldquo;NOT-IC-20-024 without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Requests be one year support only. Research Strategy section the application limited 6 pages. Only existing awardees a participating Institute Center eligible apply. Administrative supplement applications toPA-18-591must the application form package the Competition ID contains ldquo;FORMS-F-ADMINSUPP. addition, process Streamlined Submissions using eRA Commons cannot used this initiative. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response this FOA order facilitate efficient processing the request. Page Limits: NIH consider supplements a Research Strategy no than 6 pages, addition the abstract. Research Strategies Collaborative Research Fund Submitted applications collaboration/training must include: Description the goals the collaboration/training how will enhance research the NIH-supported parent grant Details the supplement's specific aims, research design, methods data analysis Background significance the proposed research/training its relevance the goals the BRCP the mission the participating NIH Institutes Centers unique opportunities offered this collaboration/training, the reciprocal U.S. Japan) entity the project should clearly delineated Description the qualifications the Japanese host the research facilities resources the host institution Submitted applications collaboration/training must include letter invitation biosketch the Japanese host(s). Workshop Fund Submitted applications joint workshops must include: Description the importance the proposed workshop investigators the field the larger neuroscience community Relevance the workshop the goals the BRCP the mission the participating NIH Institutes Centers Background anticipated outcomes Description the meeting content, including topics, sessions, a tentative agenda Plans foster potential collaborations between U.S. Japanese participants Justification the proposed workshop location duration Composition role the organizing committee, the name credentials key participants i.e., presenters, moderators) Plans disseminate information generated the proposed workshop the larger scientific community. Plans the inclusion junior investigators, women, racial/ethnic minorities, persons disabilities. Review Process: Administrative supplement requests undergo administrative evaluation NIH Program staff the participating Institutes Centers. Reporting:Reporting requirements be specified the terms conditions award applicable the supplemental activities. most non-competing continuation applications, progress report budget the supplement must included with, clearly delineated from, progress report budget the parent award. progress report must include information the activities supported the supplement even support future years not requested. Final Report Within month the completion all collaborative research/training efforts workshops, U.S. BRCP supported investigators required submit final report the NIH, detailing following information: Project objectives Significance Results/findings including list publications, presentations, dissemination material research grant applications resulting the collaboration/training workshop Outcome collaboration/training workshop how benefits NIH supported research plans continued collaboration the Japanese investigator(s) Inquiries Please direct inquiries to: Scientific/Research Contact(s) Stacey D. ChambersNational Institute Neurological Disorders Stroke NINDS)Telephone: 301-496-0690 Email:chambers@ninds.nih.go Coryse St. Hillaire-Clarke, Ph.D.National Institute Aging NIA)Telephone: 301-827-6944Email: sthillaireclacn@mail.nih.gov Shumin Wang, Ph.D.National Institute Biomedical Imaging Bioengineering NIBIB)Telephone: 301-594-9001Email: shumin.wang@nih.gov Da-Yu Wu, Ph.D. National Institute Drug Abuse NIDA) Telephone: 301-443-1887 Email: wudy@nida.nih.gov Susan L. Sullivan, Ph.D.National Institute Deafness amp; Communication Disorders NIDCD)Telephone: 301-451-3841Email: sullivaS@nidcd.nih.gov Yolanda F. Vallejo, Ph.D.National Institute Dental Craniofacial Research NIDCR)Telephone: 301-827-4655Email: Yolanda.Vallejo@nih.gov Jonathan A. Hollander, Ph.D. National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-9467 Email: jonathan.hollander@nih.gov Miri Gitik, Ph.D. National Institute Mental Health NIMH) Telephone: 301-827-3523 Email: miri.gitik@nih.gov Inna Belfer, M.D., Ph.D. National Center Complementary Integrative Health NCCIH) Telephone: 301-435-1573 Email: inna.belfer@nih.gov Danilo A. Tagle, Ph.D., M.S. National Center Advancing Translational Sciences NCATS) Telephone: 301-594-8064 Email: danilo.tagle@nih.gov Financial/Grants Management Contact(s) Chief Grants Management Officer National Institute Neurological Disorders Stroke NINDS) Email: ChiefGrantsManagementOfficer@ninds.nih.gov Jennifer Edwards National Institute Aging NIA) Telephone: 301-827-6689 Email: edwardsj@mail.nih.gov James Huff National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4786 Email: huffj@mail.nih.gov Cheryl Nathaniel National Institute Drug Abuse NIDA) Telephone: 202-526-0108 Email: nathanic@nida.nih.gov Christopher MyersNational Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-402-0909 Email: myersc@mail.nih.gov Dede Rutberg National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-4798 Email: rutbergd@mail.nih.gov James R. Williams National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-1403 Email: james.williams3@nih.gov Tamara KeesNational Institute Mental Health NIMH)Telephone: 301-443-8811Email: tkees@mail.nih.gov Shelley M. CarowNational Center Complementary Integrative Health NCCIH)Telephone: 301-594-3788Email: carows@mail.nih.gov Karen BrummettNational Center Advancing Translational Sciences NCATS)Telephone: 301-594-6268Email: Karen.Brummett@nih.gov

The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

Notice Special Interest: Administrative Supplements NIH grants Add Expand Research Focused Maternal Mortality Notice Number: NOT-OD-20-104 Key Dates Release Date: 05, 2020 First Available Due Date: 05, 2020 Expiration Date: June 23, 2020 Related Announcements PA-18-591 - Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) Issued Office The Director, National Institutes Health OD) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) National Institute Alcohol Abuse Alcoholism NIAAA) - New participating organization of 05/08/2020 due dates on/after 05/08/2020 applications this funding opportunity announcement should fall within mission the Institutes/Centers. following NIH Offices co-fund applications assigned those Institutes/Centers. Division Program Coordination, Planning Strategic Initiatives, Office Disease Prevention ODP) Office Behavioral Social Sciences Research OBSSR) Office Research Women's Health ORWH) Purpose Office the Director the National Institutes Health NIH) announces opportunity investigators relevant active NIH-supported grants the participating Institutes listed above address scientific priorities will lay foundation the Implementing Maternal health PRegnancy Outcomes Vision Everyone IMPROVE), is development. estimated 700 women die year the U.S. conditions related or associated pregnancy childbirth highest rate among developed nations), over 50,000 women experience severe maternal morbidity SMM). response the rising maternal mortality MM) the United States U.S.), IMPROVE initiative support research how mitigate preventable MM, decrease SMM, promote health equity the U.S. IMPROVE aim use integrated approach understand biological, behavioral, sociocultural, structural factors contributing MM/SMM building evidence base improved care outcomes specific populations regions the country. IMPROVE be multipronged, innovative research initiative designed target health disparities populations disproportionately affected MM/SMM, including African American AA), American Indian/Alaskan Native AI/AN), Asian Pacific Islander, Hispanic/Latina, very young women women advanced maternal age, people disabilities. Geographical disparities social determinants health SDoH), including education, racism, socioeconomic standing also addressed the IMPROVE approach. Causes SMM MM multifaceted. the U.S., leading causes cardiovascular disease, hemorrhage, infection. Significant contributing factors include comorbid conditions e.g., diabetes, obesity, mental health issues, substance disorders) structural health care system factors. Therefore, is necessary implement comprehensive strategies address preventable contributors SMM/MM disproportionately affected populations. order rapidly improve our understanding the leading causes pregnancy-related pregnancy-associated morbidity, including SMM, MM during pregnancy, delivery, up one year post-partum to expand research development risk stratification approaches mitigation strategies, NIH soliciting submission applications Administrative Supplements active social, biobehavioral, fundamental science awards. Applicants encouraged incorporate where appropriate community partnerships focus disparities race ethnicity, age, disability status, geographic region within overarching research areas. Projects involve secondary analysis existing data collection new data. Applicants responding this NOSI strongly encouraged describe plans rapid sharing data results well innovative data analytics approaches Goal 3, NIH Strategic Plan Data Science). Applications response this NOSI should aligned one more these equally significant goal Goal 1: Incorporate community partnerships participation domestic MM pregnancy-related pregnancy-associated morbidity research resolve health disparities attain equity maternal health. Goal 2: Expand research the leading causes MM pregnancy-related pregnancy-associated morbidity the U.S. strengthen evidence-based care prevention strategies improve outcomes. Goal 3: Develop integrated understanding pregnancy-related pregnancy-associated morbidity MM causes, including underlying comorbidities, mechanisms identify preventable risk factors develop early effective interventions. Areas research interests include are limited the following: Identify determinants risk protection detect most vulnerable populations provide points intervention cardiovascular, stroke, abnormal placentation, hemorrhage, gestational diabetes, infection immunity, mental health, substance abuse research areas. Determine factors related race, ethnicity, age affect underlying leading causes, contributors, mechanisms MM/pregnancy-related pregnancy-associated morbidity. Identify multi-level individual, interpersonal, community, sociocultural) determinants maternal health disparities, well factors contribute optimal maternal outcomes high risk communities. omics” other novel technologies existing well-characterized cohorts in clinical trials pregnant women accelerate identification diagnostic, predictive, therapeutic biomarkers including brain structure function alterations) pregnancy-related adverse maternal health outcomes. Determine contribution immune system dysregulation autoimmunity during pregnancy the postpartum period leading poor pregnancy maternal health outcomes. Identify predictors contribution maternal mortality postpartum anxiety depression harmful substance and drug overdoses, including relevant environmental social factors e.g., institutional racism, access care, intimate partner violence, etc.) affect them. Develop and/or test interventions addressing stress, perinatal postpartum depression harmful substance e.g., peer support, complementary health approaches, strategies coordinate integrate OB/GYN mental health substance treatment services) assess impact maternal health outcomes. Develop approaches interventions target pregnancy-related cardiovascular disease and/or underlying cardiovascular risk factors during perinatal postnatal periods assess impact maternal health status. Identify barriers opportunities design strategies implementing clinical guidelines blood pressure management, physical activity, diet tailored high risk communities. Link establish feasibility linking existing MM/pregnancy-related pregnancy-associated morbidity datasets, electronic health records, clinical biomarker data existing national cohorts, biobank data, national surveys registries. Develop tools modify existing tools e.g. Smartwatch ECG, blood pressure, sleep monitor heart rate monitor, devices measure real-time stress level, wearable devices detect postpartum depression, predictive modeling tools, etc.) recognize pregnancy related warning signs. Identify, monitor, target pregnancy-related pregnancy-associated morbidity/MM-related ischemic stroke arterial venous), intra-cerebral hemorrhage, epilepsy, migraine, nervous system infections, headache, encephalopathy syndromes, cognitive impairment. Develop strategies enhancing community partnerships engages women their families, community healthcare providers systems, local governments identify barriers and community-specific opportunities optimal maternal health equity. Design test strategies improve interdisciplinary coordinated care, particularly during transition periods, prenatal one year postpartum prevent mortality adverse health outcomes. Applications incorporate community partnerships interdisciplinary research strongly encouraged. administrative supplements extend work awarded the parent grant, proposal needs be within scope the project is already supported. Supplements awards clinical trials allowed. Supplement applicants must demonstrate the additional NIH funding advance science and/or medicine above current funding level. Application Submission Information Applications this initiative must submitted using following opportunity its subsequent reissued equivalent: PA-18-591 - Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional instructions the SF424 R&R) Application Guide and PA-18-591 (or reissue) must followed, the following additions: Application Due Date(s) – June 22, 2020 5:00 PM local time applicant organization. funding consideration, applicants must include NOT-OD-20-104” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. project budget periods must within currently approved project period the existing parent award. Individual requests be more 150,000 direct costs the entire project period. project period be limited 1 year. Research Strategy section the application limited 6 pages should include following information Discussion the scientific rationale relevance maternal mortality. Administrative supplement applications PA-18-591 must the application form package the Competition ID contains FORMS-E-ADMINSUPP”. FOA be reissued application form packages containing FORMS-F-ADMINSUPP” May 25, 2020. Submissions the reissued FOA be accepted or after 25, 2020 through expiration date this Notice. process Streamlined Submissions using eRA Commons cannot used this initiative. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response this FOA order facilitate efficient processing the request Review Process IC conduct administrative reviews applications will be prioritized NIH staff the Maternal Mortality Task Force. Criteria: Priority be given projects incorporate community needs perspectives that focus a population disproportionately affected MM/SMM. NIH staff review following: Does work proposed address or of goals defined earlier this notice NOT-OD-20-104)? the project designed advance our understanding the mechanisms, interventions, risk profiles pregnancy-related pregnancy-associated morbidity/MM the U.S.? Does supplement propose address or of leading preventable causes pregnancy-related pregnancy-associated morbidity/MM the U.S. outlined this notice NOT-OD-20-104)? not, there strong justification addressing preventable causes? the proposal address pregnancy-related pregnancy-associated morbidity/MM one more high risk populations based race/ethnicity, age, geographic region? the work proposed within scope the active parent award? the parent award progressing satisfactorily/according planned timeline milestones? the proposed project technically feasible within supplement budget funding period? the overall strategy, methodology, analyses proposed the supplement application well-reasoned appropriate accomplish activities the proposed project period?   Inquiries Please direct inquiries to: Nahida Chakhtoura Eunice Kennedy Shriver National Institute Child Health Human Development NICHD)National Institute Child Health Human Development Telephone: 301-435-6872 Email:  nahida.chakhtoura@nih.gov Soju Chang National Center Advancing Translational Sciences NCATS) Telephone: 301-827-9206 Email: soju.chang@nih.gov Della White National Center Complementary Integrative Health Telephone: 301-827-6358 Email: whitede@mail.nih.gov Lisa Neuhold National Eye Institute Telephone: 301-451-2020 Email: lneuhold@nei.nih.gov Jyoti Dayal National Human Genome Research Institute Telephone: 301-480-2307 Email: jyotig@mail.nih.gov NHLBI IMPROVE Initiative National Heart, Lung, Blood InstituteEmail: NHLBI_IMPROVEinitiative@nhlbi.nih.gov Rosaly Correa-de-Araujo National Institute Aging Telephone: 301-496-6762 Email: rosaly.correa-de-araujo@nih.gov Juliane Caviston National Institute Allergy Infectious Diseases Telephone: 301-761-5094 Email: juliane.caviston@nih.gov Marisol Espinoza-Pintucci National Institute Arthritis Musculoskeletal Skin Diseases Telephone: 301-827-6959 Email: marisol.espinoza-pintucci@nih.gov Minki Chatterji National Institute Drug Abuse Telephone: 301-827-5435 Email: minki.chatterji@nih.gov Trinh T. Ly National Institute Deafness Other Communication Disorders Telephone: 301-435-4085 Email: trinh.ly@nih.gov Christine Maric-Bilkan National Institute Diabetes Digestive Kidney Diseases Telephone: 301-435-0486 Email: christine.maric-bilkan@nih.gov Zuzana Justinova National Institute General Medical Sciences Email: zuzana.justinova@nih.gov Lauren D. Hill National Institute Mental Health Telephone: 301-443-2638 Email: hillla@mail.nih.gov Jennifer Alvidrez National Institute Minority Health Health Disparities Telephone: 301-594-9567 Email: jennifer.alvidrez@nih.gov Adam Hartman National Institute Neurological Disorders StrokeScientific/Research Contact Telephone: 301-496-9135 Email: adam.hartman@nih.gov Richard T. Benson National Institute Neurological Disorders StrokeScientific/Research Contact Telephone: 301-827-9071 Email: richard.benson@nih.gov Chief Grants Management Officer National Institute Neurological Disorders StrokeFinancial/Grants Management Contact Email: ChiefGrantsManagementOfficer@ninds.nih.gov Sung Sug Sarah) Yoon National Institute Nursing Research Telephone: 301-402-6959 Email: sungsug.yoon@nih.gov Hua-Chuan Sim National Library Medicine Telephone: 301-594-4882 Email:   simh@mail.nlm.nih.gov Erica Spotts Office Behavioral Social Sciences Research Telephone: 301-594-2105 Email: spottse@mail.nih.gov Courtney Coombes Office the Director Telephone: 301-827-2408 Email: courtney.coombes@nih.gov Elizabeth Neilson Office Disease Prevention Telephone: 301-827-5578 Email: neilsone@mail.nih.gov Dave Thomas Office Research Women’s Health Telephone: 301-435-1313 Email: david.thomas@nih.gov Deidra Roach, M.D. National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-5820 Email: droach@mail.nih.gov

The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.